Andrew S Kraft MD
Director of the University of Arizona Cancer Center Sydney E. Salmon Endowed Chair Associate Vice President for Oncology Programs for the University of Arizona Health Sciences Professor of Medicine in the Department of Medicine, Division of Hematology/Onc
Join to view full profile
171 Ashley AveCharleston, SC 29425
Phone+1 843-792-1414
Fax+1 520-694-4085
Dr. Kraft is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1982 - 1983
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1975 - 1978
Perelman School of Medicine at the University of PennsylvaniaClass of 1975
Certifications & Licensure
CO State Medical License 1996 - 2027
AZ State Medical License 2014 - 2022
SC State Medical License 2004 - 2015
AL State Medical License 1983 - 1996
MD State Medical License 1978 - 1990
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 1993
Clinical Trials
- Bryostatin 1 in Treating Patients With Stage IV Breast Cancer
- Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2004 Jun 08
- Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer Start of enrollment: 2007 Jan 16
Publications & Presentations
PubMed
- 14 citationsPIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion.Corbin C Jensen, Amber N Clements, Hope Liou, Lauren E Ball, Jennifer R Bethard
The Journal of Cell Biology. 2023-06-05 - 24 citationsAn XBP1s-PIM-2 positive feedback loop controls IL-15-mediated survival of natural killer cells.Shoubao Ma, Jingjing Han, Zhenlong Li, Sai Xiao, Jianying Zhang
Science Immunology. 2023-03-17 - 17 citationsOER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma.Julio Alvarenga Thiebaud, Vinod Ravi, Samuel Litwin, Scott M Schuetze, Sujana Movva
Cancer. 2022-10-01
Press Mentions
Shop TalkJuly 20th, 2019- Shop TalkDecember 10th, 2016
Dr. William Cance Hired to Lead University of Arizona Cancer Center in PhoenixNovember 6th, 2016
Grant Support
- Regulation of RNA Decapping and Degradation: A novel approach to prostate cancer therapyVORTEX BIOTECHNOLOGY CORPORATION2023–2025
- Senior LeadershipNational Cancer Institute2009–2012
- Program Planning And EvaluationNational Cancer Institute2009–2012
- Medical University Of South Carolina - Cancer Center Support GrantNational Cancer Institute2009–2012
- Developmental FundsNational Cancer Institute2009–2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
